A United States HIV provider survey of antiretroviral therapy management in people living with HIV with co-occurring conditions.

Sonya Krishnan¹, Marina B Martinez Rivera¹, Christopher K Lippincott¹, Maunank Shah^2,3

¹Department of Medicine, Division of Infectious Diseases, Johns Hopkins University School of Medicine, Baltimore, MD, USA.

²Department of Medicine, Division of Infectious Diseases, Johns Hopkins University School of Medicine, Baltimore, MD, USA. mshah28@jhmi.edu.

³, 1550 Orleans St, CRB Building, 1M-10, Baltimore, MD, 21287, USA. mshah28@jhmi.edu.

PubMed PMC DOI PDF

Abstract

INTRODUCTION: Simplified HIV treatment guidelines favor integrase strand transfer inhibitors (INSTIs). However, non-infectious comorbidities and co-occurring conditions (i.e. pregnancy) often necessitate individualized antiretroviral therapy (ART) regimens. This study aimed to characterize United States HIV provider strategies for ART selection when faced with concomitant health conditions. METHO…

Create a free account to keep reading

Free members get 10 full research views every month across publications, clinical trials, FDA clearances, adverse events, and NIH grants. No credit card required.

Create Free Account Sign In

Want unlimited research access? See Pro plans

Data Accuracy Notice: Research intelligence on Health AI Central is aggregated from public sources (PubMed, ClinicalTrials.gov, FDA, NIH, CMS, and others) and refreshed nightly. Classifications and derived metrics are produced by automated methods described in our Methodology. We recommend verifying critical data points against the primary sources before making decisions.